Navigation Links
STAAR Surgical Provides Outlook on Third Quarter 2011 Revenue and Cash
Date:10/20/2011

MONROVIA, Calif., Oct. 20, 2011 /PRNewswire/ -- STAAR Surgical Company (NASDAQ: STAA) today provided an outlook on its financial results for the third quarter ended September 30, 2011. The Company is providing this information prior to the issuance of final results on Monday, October 24, 2011 in order to facilitate communications with its sales team, investors and other attendees of the American Association of Ophthalmology (AAO) Annual Meeting which begins tomorrow and continues through Tuesday in Orlando, FL.  All preliminary financial information is unaudited and the normal review by the Company's outside auditors is not yet completed.

Revenue for the third quarter is expected to be $15.3 million, which is 16% higher than the revenue generated in the third quarter of 2010.  The growth was driven by a 31% increase in Visian ICL sales.  Gross margin percentage continued to expand from both the prior year and prior quarter as a result of increased ICL mix and improved margins in both ICLs and IOLs.  The Company estimates that it generated approximately $2.5 million in cash from operations during the third quarter and will end the quarter with approximately $16.9 million in cash on its balance sheet, which is a record high for the Company.  

"The 16% revenue growth fueled by a 31% increase in Visian ICL sales marks another terrific result from the execution of our strategy to focus on high margin Visian ICL products," said Barry G. Caldwell, President and CEO.  "With the expanded range of treatments available with our V4b ICL launched in European markets, we can now effectively compete for all LASIK procedures as we saw with the overall continued strong acceptance and momentum of ICLs during the third quarter.  In October we began shipments of the next generation V4c with new CentraFLOW™ technology utilizing the KS-AquaPORT™
'/>"/>

SOURCE STAAR Surgical Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. STAAR Surgical Reports Progress on Japan Application for Approval of Visian Toric Implantable Collamer® Lens (TICL)
2. STAAR Surgical to Present at the 2011 Canaccord Genuity Growth Conference
3. STAAR Surgical Reports 19% Revenue Growth Second Quarter
4. STAAR Surgical Reports First Quarterly Profit from Continuing Operations Since 2000
5. STAAR Surgicals nanoFLEX™ Collamer® IOL Receives CE Mark Approval
6. STAAR Surgical Launches Second Phase of Visian ICL Direct-to-Consumer Advertising Campaign
7. STAAR Surgical Enters Into Distribution Agreement With Ellex in Australia
8. STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million
9. STAAR Surgicals Visian® ICL Surpasses 200,000 Implants
10. STAAR Surgical Reports Continued Double Digit Core Revenue Growth
11. STAAR Surgical Launches New Visian ICL™ Product Line Extensions at ESCRS
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... , May 26, 2015  MGC Diagnostics Corporation (NasdaqCM: MGCD), ... to discuss its financial results for the second quarter of ... at 4:30 p.m. ET on Tuesday, June 2, 2015. The ... fiscal 2015 at the close of the markets on Tuesday, ... 317-6789 or (412) 317-6789 to access the conference call, or ...
(Date:5/26/2015)... Boehringer Ingelheim today announced that the ... STIOLTO™ RESPIMAT ® (tiotropium bromide and olodaterol) ... long-term, once-daily maintenance treatment of airflow obstruction in ... chronic bronchitis and/or emphysema. STIOLTO RESPIMAT is not ... COPD. COPD, which includes chronic bronchitis ...
(Date:5/26/2015)... 2015 Mast Therapeutics, Inc. ... its molecular adhesion and sealant technology (MAST) platform ... heart failure, and arterial disease, today reported that ... extension study of vepoloxamer (MST-188) in sickle cell ... enroll patients who have completed the Company,s Phase ...
Breaking Medicine Technology:MGC Diagnostics Corporation to Report Second Quarter Fiscal 2015 Financial Results on Tuesday, June 2, 2015 2FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 2FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 3FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 4FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 5FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 6FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 7FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 8FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 9FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 10FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 11FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 12FDA Approves Boehringer Ingelheim's STIOLTO RESPIMAT Inhalation Spray as Once-Daily Maintenance Treatment for COPD 13Mast Therapeutics Announces Initiation Of EPIC-E Study 2Mast Therapeutics Announces Initiation Of EPIC-E Study 3Mast Therapeutics Announces Initiation Of EPIC-E Study 4Mast Therapeutics Announces Initiation Of EPIC-E Study 5
... 15, 2011 Pharmaceutical companies are dramatically increasing ... meet the demands of a patient-empowered, data-driven, outcomes-focused ... alone, pharmaceutical company investment in smart phone apps, ... other programs increased 78%, as companies embrace a ...
... Unilife Corporation ("Unilife" or "Company") (Nasdaq: ... the three and six months ended December 31, 2010 (Fiscal ... Completed, on-schedule, the construction of a new ... staff now working out of the new facility ...
Cached Medicine Technology:Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 2Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 3Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 4Pharmaceutical Industry Rapidly Expanding Partnerships With New Entrants in Health Care Space, Ernst & Young Finds 5Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 2Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 3Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 4Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 5Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 6Unilife Corporation Announces Financial Results For Fiscal Year 2011 Second Quarter 7
(Date:5/26/2015)... NC (PRWEB) May 26, 2015 ... compliance solutions for the health and human services market, ... to meet demand. After strong attendance and participation in ... groups, and give their annual user conference an exciting ... Relias customers to come together and discuss best practices, ...
(Date:5/26/2015)... May 26, 2015 Mr. Larry Westenberg ... expert in Neuro-Linguistic Programming, or NLP. Mr. Westenberg ... Rapid Resolution Therapy® or RRT®. While many people ... and applied it to specific areas, Mr. Westenberg has ... for over 20 years. He works with people ...
(Date:5/26/2015)... Santa Rosa, CA (PRWEB) May 26, 2015 ... Management and Analytics solutions for more than 15 years, ... from the National Committee for Quality Assurance (NCQA) for ... today. , “We are proud of the work we ... years and are grateful for the acknowledgement from NCQA ...
(Date:5/26/2015)... Pass, OR (PRWEB) May 26, 2015 ... always fatal if not caught early. Melanoma is also ... water advocate Sharon Kleyne, the melanoma rate is on ... radiation. While the melanoma risk for indoor tanning salon ... these establishments. The most recent ban, in Pennsylvania, coincides ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Writers ... Editor with the Vasont® CCMS to make creating, ... Systems, a top component content management system (CCMS) ... (VUI) extension supports oXygen XML Editor Version 17.0, ... Vasont Universal Integrator extension merges key editorial functionality ...
Breaking Medicine News(10 mins):Health News:Relias Learning Expands User Groups and Industry Influence 2Health News:Relias Learning Expands User Groups and Industry Influence 3Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 2Health News:i2iTracks Earns NCQA 2014 PCMH Prevalidation 3Health News:Skin Cancer Awareness Month: Pennsylvania Ban of Teens from Tanning Salons Is Praised by Fresh Water Advocate Sharon Kleyne 2Health News:Skin Cancer Awareness Month: Pennsylvania Ban of Teens from Tanning Salons Is Praised by Fresh Water Advocate Sharon Kleyne 3Health News:Vasont Systems Certifies the Integration between the Vasont® Component Content Management System and oXygen® XML Editor 17.0 2
... changes and inflammation has been awarded a Wellcome Trust ... The research programme at the National Institute for Health ... Professor Julian Davis, a consultant endocrinologist at Manchester Royal ... Biomedicine Research Group. He is working with Professor ...
... the Walter and Eliza Hall Institute in Melbourne, Australia, has ... further research into an aggressive and highly lethal form of ... the cell lining (epithelium) of the ovary, accounts for 90 ... still poorly understood, and recent research has revealed that it ...
... TUESDAY, Oct. 26 (HealthDay News) -- New research challenges previous ... with a certain genetic mutation. While guidelines have recommended ... their KRAS gene should not receive the targeted ... of these patients might actually benefit from taking the drug. ...
... , TUESDAY, Oct. 26 (HealthDay News) -- ... physicians, and this may be one reason for U.S. ... new study. Researchers looked at the wages of ... them into four broad categories: primary care; surgery; internal ...
... School of Medicine and The Children,s Hospital have taken a ... serious liver diseases in infants. The disease is called ... through which bile, crucial for digestion, flows to the small ... one in 10,000 births. But it,s life-threatening. "It ...
... In the 15 minutes a primary care doctor typically ... ailment, help manage ongoing health issues and provide preventive care. ... immediate mental health needs of patients is an ongoing challenge. ... Michigan Health System, however, points to an encouraging strategy for ...
Cached Medicine News:Health News:Manchester team wins $1.9 million grant for 'cell control' study 2Health News:VCA fellowship funding to extend ovarian cancer research 2Health News:New Insights on Who Should Take Erbitux for Colon Cancer 2Health News:Primary Care MDs at Low End of Pay Scale, Study Finds 2Health News:Breakthrough in understanding life-threatening childhood liver disease 2Health News:Follow-ups prove powerful tool for treating depression in primary care 2
The flexible nature of the vinyl allows the user to reach deeper into the chamber and allows for a greater comfort when working inside the glove box over a long period of time compared to any rigid s...
This chamber is designed to provide a large workspace and gloveless dexterity in closed environment industrial, research and development, quality control packaging applications. Atmospheres of nitrog...
... MACS MICS is a fast, ... mixtures for growth of microaerophilic organisms.Designed ... jar-based MACS MICS runs at 1% ... envelopes and is suitable for growth ...
The airlock allows anaerobic entry of large flasks, vessels, and up to 90 plates at a time....
Medicine Products: